PD20-09 ONOBOTULIUMTOXIN A VERSUS KENALOG FOR INTRAVAGINAL TRIGGER POINT INJECTIONS IN THE TREATMENT OF CHRONIC PELVIC PAIN

INTRODUCTION AND OBJECTIVES:Chronic pelvic pain in women is often due to pelvic muscle dysfunction and hypertonicity. In this study we compared outcomes of patients with chronic pelvic pain undergoing transvaginal trigger point injections (TPI) with triamcinolone (steroid) vs. onabotulinumtoxinA (Botox).METHODS:A prospective double-blind study was conducted. Patients were randomized (1:1) to receive in-office pelvic floor muscle injections with either a mixture of triamcinolone and ropivacaine followed by saline or injections of ropivacaine followed by a mixture of Botox 200 units and saline. Three bilateral injections were performed on each side of the pelvic floor. Statistical analysis compared the treatment groups at baseline and 1-month, 3-month and 6-month post-injection.RESULTS:Twenty-one patients underwent TPI (11 steroid, 10 Botox). Primary diagnosis included myalgia, urinary system related symptoms, muscle spasms, and chronic pelvic pain. There was no statistical difference in baseline demographi...